Lundbeck Eyes US, China Investment as Drug Rewards Lag in Europe

H. Lundbeck A/S will focus its capital investments on the US and China rather than Europe as the region faces growing pressure to incentivize innovation, according to the Danish drugmaker’s chief executive officer.